Search clinical trials for: Close-loop FiO2 controller

Total 323 results

Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Type 1 Diabetes

Canada
Medstar Health Research Institute
Latham Fund

Not yet recruiting

Pilot Study of Intrapartum Insulin Pump

Diabetes | Pregnancy | Diabetes (Insulin-requiring, Type 1 or Type 2)
University Hospital, Montpellier
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia (DCLP2)

Type 1 Diabetes Mellitus With Hypoglycemia

France
Rabin Medical Center

Completed

Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home

Type 1 Diabetes

Israel, Germany, Slovenia
Centre Oscar Lambret

Completed

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Malignant Mesothelioma

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Breast Cancer | Osteoporosis

United States, Canada
Hebrew SeniorLife
GlaxoSmithKline; Merck Sharp & Dohme LLC; National Institute on Aging (NIA)

Completed

Secondary Prevention of Osteoporosis

Osteoporosis

United States
Colgate Palmolive

Completed

Clinical Efficacy of a Toothpaste on Hypersensitivity Reduction (Yeaple)

Hypersensitivity

United States
Guangzhou General Hospital of Guangzhou Military...

Unknown

Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index

Anesthesia

China
University of Arizona

Unknown

Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes (MET)

Type 2 Diabetes Mellitus
Asan Medical Center
Chungnam National University

Completed

Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection

Hypocalcemia

Korea, Republic of
Institut de Recherches Cliniques de Montreal

Completed

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Type 1 Diabetes

Canada
SCRI Development Innovations, LLC
Eli Lilly and Company; Genentech, Inc.

Terminated

Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

Lung Cancer

United States
Hopital Foch

Completed

One-year Mortality After Surgery and Low Bispectral Index (ELA)

General Anesthesia

France
Chinese PLA General Hospital
309th Hospital of Chinese People's Liberation Army; Beijing Naval General Hospital and other collaborators

Unknown

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Leukemia
Acerta Pharma BV

Completed

A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

Healthy Participants

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Leukemia

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage IA Hodgkin Lymphoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Recurrent Colorectal Carcinoma | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer

United States
University of Southern California
National Cancer Institute (NCI); Amgen

Terminated

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...

United States

Search clinical trials for: Close-loop FiO2 controller

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations